OA11169A - Pharmaceutical compositions of tizoxanide and nitazoxanide - Google Patents

Pharmaceutical compositions of tizoxanide and nitazoxanide Download PDF

Info

Publication number
OA11169A
OA11169A OA9900239A OA9900239A OA11169A OA 11169 A OA11169 A OA 11169A OA 9900239 A OA9900239 A OA 9900239A OA 9900239 A OA9900239 A OA 9900239A OA 11169 A OA11169 A OA 11169A
Authority
OA
OAPI
Prior art keywords
acid
composition
formula
compound
particles
Prior art date
Application number
OA9900239A
Other languages
English (en)
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11169(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of OA11169A publication Critical patent/OA11169A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
OA9900239A 1997-05-07 1999-10-29 Pharmaceutical compositions of tizoxanide and nitazoxanide OA11169A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
OA11169A true OA11169A (en) 2003-04-25

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900239A OA11169A (en) 1997-05-07 1999-10-29 Pharmaceutical compositions of tizoxanide and nitazoxanide

Country Status (35)

Country Link
EP (2) EP1005342B1 (no)
JP (1) JP3739802B2 (no)
KR (2) KR100576646B1 (no)
CN (2) CN1158074C (no)
AP (1) AP1103A (no)
AR (1) AR057242A2 (no)
AT (2) ATE281166T1 (no)
AU (1) AU740022B2 (no)
BG (2) BG109365A (no)
BR (1) BR9808722A (no)
CA (2) CA2418634C (no)
CZ (2) CZ298270B6 (no)
DE (2) DE69827417T2 (no)
DK (2) DK1005342T3 (no)
EA (2) EA002920B1 (no)
EE (1) EE04870B1 (no)
ES (2) ES2150404T3 (no)
GE (1) GEP20032970B (no)
HK (1) HK1025907A1 (no)
HU (1) HU229641B1 (no)
IL (2) IL132516A (no)
IS (1) IS2087B (no)
LV (1) LV12492B (no)
ME (1) ME00530B (no)
NO (2) NO313983B1 (no)
NZ (2) NZ513881A (no)
OA (1) OA11169A (no)
PL (1) PL193275B1 (no)
PT (2) PT1005342E (no)
RO (1) RO120605B1 (no)
SI (1) SI20149B (no)
SK (2) SK283947B6 (no)
TR (1) TR199902733T2 (no)
UA (2) UA57079C2 (no)
WO (1) WO1998050035A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
AP2907A (en) 2006-01-09 2014-05-31 Romark Lab Lc Viral hepatitis treatment
KR101697800B1 (ko) * 2009-02-13 2017-01-18 로마크 레버러토리즈, 엘.씨. 니타족사니드의 서방성 제약 제형
CN102803203B (zh) 2009-05-12 2016-05-11 罗马克实验室有限公司 卤代烷基杂芳基苯甲酰胺化合物
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
EP2808019B1 (en) 2012-01-27 2019-09-25 Siegfried Rhein S.A. De C.V. Improved nitazoxanide composition and preparation method thereof
TW201619142A (zh) * 2014-11-11 2016-06-01 羅馬克實驗室有限公司 利用替唑尼特（ｔｉｚｏｘａｎｉｄｅ）、其類似物或鹽類之前驅藥的組成物及治療方法
JP2021512852A (ja) 2018-02-02 2021-05-20 リップル セラピューティクス コーポレーション ステロイド二量体を含むガラス製剤およびその使用
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
CN1552322A (zh) 2004-12-08
NO20021832D0 (no) 2002-04-18
AP1103A (en) 2002-09-04
AU7289598A (en) 1998-11-27
NZ513881A (en) 2002-10-25
AR057242A2 (es) 2007-11-21
ES2150404T1 (es) 2000-12-01
CA2288003C (en) 2003-10-21
CN1158074C (zh) 2004-07-21
PT1005342E (pt) 2003-02-28
ATE281166T1 (de) 2004-11-15
DE69827417T2 (de) 2005-10-27
IL155799A (en) 2004-08-31
HUP0003330A3 (en) 2002-10-28
BG103958A (en) 2000-07-31
UA57079C2 (uk) 2003-06-16
DK1222921T3 (da) 2005-03-07
BR9808722A (pt) 2000-07-11
AU740022B2 (en) 2001-10-25
DE69827417D1 (de) 2004-12-09
NO995406L (no) 2000-01-04
CN1255060A (zh) 2000-05-31
EP1005342B1 (en) 2002-12-04
IL132516A (en) 2003-12-10
NO20021832L (no) 2000-01-04
EP1005342A1 (en) 2000-06-07
HK1025907A1 (en) 2000-12-01
SI20149A (sl) 2000-08-31
TR199902733T2 (xx) 2000-03-21
JP3739802B2 (ja) 2006-01-25
PT1222921E (pt) 2005-02-28
KR20010020322A (ko) 2001-03-15
LV12492B (en) 2001-01-20
PL336805A1 (en) 2000-07-17
ES2232687T3 (es) 2005-06-01
DE69809928T2 (de) 2003-04-24
WO1998050035A1 (en) 1998-11-12
CA2418634A1 (en) 1998-11-12
LV12492A (en) 2000-06-20
SI20149B (en) 2001-08-31
EA200100956A1 (ru) 2002-02-28
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
CZ391199A3 (cs) 2000-07-12
EP1222921A1 (en) 2002-07-17
EE04870B1 (et) 2007-08-15
CZ298269B6 (cs) 2007-08-08
SK283946B6 (sk) 2004-05-04
EE9900578A (et) 2000-08-15
GEP20032970B (en) 2003-05-27
NO995406D0 (no) 1999-11-04
EA002920B1 (ru) 2002-10-31
ME00530B (me) 2011-10-10
EA199901012A1 (ru) 2000-08-28
ES2150404T3 (es) 2003-07-01
ATE228839T1 (de) 2002-12-15
DK1005342T3 (da) 2003-03-24
PL193275B1 (pl) 2007-01-31
CZ298270B6 (cs) 2007-08-08
EA002908B1 (ru) 2002-10-31
SK151199A3 (en) 2000-07-11
KR100426657B1 (ko) 2004-04-13
KR100576646B1 (ko) 2006-05-08
RO120605B1 (ro) 2006-05-30
CN100515420C (zh) 2009-07-22
NZ500149A (en) 2001-11-30
IS2087B (is) 2006-03-15
BG64973B1 (bg) 2006-11-30
BG109365A (en) 2006-08-31
NO313983B1 (no) 2003-01-13
CA2288003A1 (en) 1998-11-12
SK283947B6 (sk) 2004-05-04
NO335781B1 (no) 2015-02-16
JP2001503067A (ja) 2001-03-06
IL132516A0 (en) 2001-03-19
HUP0003330A2 (hu) 2001-05-28
KR20040004544A (ko) 2004-01-13
IL155799A0 (en) 2003-12-23
EP1005342A4 (en) 2001-02-07
IS5223A (is) 1999-10-19
HU229641B1 (en) 2014-03-28
UA74388C2 (uk) 2005-12-15
DE69809928D1 (de) 2003-01-16
EP1222921B1 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
RU2314831C2 (ru) Медицинские устройства, устойчивые к инфицированию
KR101955636B1 (ko) 항생제 그리고 분산제 또는 항-부착제를 포함하는 조성물
US5965590A (en) Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
LT4751B (lt) Tizoksanido ir nitazoksanido farmacinės kompozicijos
OA11169A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
US5856348A (en) Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
AU756451B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
MXPA99010215A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide